32.09
+0.25(+0.79%)
Currency In USD
| Previous Close | 31.84 |
| Open | 31.46 |
| Day High | 32.48 |
| Day Low | 30.68 |
| 52-Week High | 62.58 |
| 52-Week Low | 23.42 |
| Volume | 749,968 |
| Average Volume | 627,741 |
| Market Cap | 1.86B |
| PE | 2.69 |
| EPS | 11.92 |
| Moving Average 50 Days | 28.95 |
| Moving Average 200 Days | 38.74 |
| Change | 0.25 |
If you invested $1000 in Agios Pharmaceuticals, Inc. (AGIO) since IPO date, it would be worth $262.56 as of May 31, 2025 at a share price of $32.09. Whereas If you bought $1000 worth of Agios Pharmaceuticals, Inc. (AGIO) shares 4 years ago, it would be worth $615.93 as of May 31, 2025 at a share price of $32.09.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025
GlobeNewswire Inc.
May 28, 2025 11:00 AM GMT
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that its management team is s
Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025
GlobeNewswire Inc.
May 09, 2025 11:00 AM GMT
CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to presen
Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025
GlobeNewswire Inc.
May 02, 2025 11:00 AM GMT
CAMBRIDGE, Mass., May 02, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that its management team is scheduled to presen